116 related articles for article (PubMed ID: 2943542)
1. Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.
Greil R; Gattringer C; Schulz T; Knapp W; Radaskiewicz T; Dierich MP; Huber H
Clin Exp Immunol; 1986 May; 64(2):423-31. PubMed ID: 2943542
[TBL] [Abstract][Full Text] [Related]
2. [Immunocytologic diagnosis of leukemia and lymphoma: monoclonal antibodies in the differential diagnosis of hematologic neoplasms].
Huber H; Gattringer C; Thaler J; Peschel C
Behring Inst Mitt; 1985 Dec; (78):83-117. PubMed ID: 3914283
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
4. Expression of leucocyte function-associated antigen-1 and 7F7-antigen, an adhesion molecule related to intercellular adhesion molecule-1 (ICAM-1) in non-Hodgkin lymphomas and leukaemias: possible influence on growth pattern and leukaemic behaviour.
Stauder R; Greil R; Schulz TF; Thaler J; Gattringer C; Radaskiewicz T; Dierich MP; Huber H
Clin Exp Immunol; 1989 Aug; 77(2):234-8. PubMed ID: 2673591
[TBL] [Abstract][Full Text] [Related]
5. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
6. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
Vik DP; Fearon DT
J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
[TBL] [Abstract][Full Text] [Related]
7. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
[TBL] [Abstract][Full Text] [Related]
8. Immunopathology of non-Hodgkin lymphomas.
Huber H; Gattringer C; Knapp W; Stein H
Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
[TBL] [Abstract][Full Text] [Related]
9. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
10. Cell-surface-marker phenotyping in patients with leukemic non-Hodgkin lymphomas (NHL) of low and intermediate malignancy.
Herrmann F; Wirthmüller R
Immunobiology; 1982 Oct; 163(1):77-94. PubMed ID: 7173978
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous mouse erythrocyte-rosette formation in chronic lymphocytic leukaemia.
Kuhlein E; Laurent G; Rigal F; Delsol G; Pris J; Ducos J
Clin Exp Immunol; 1982 Feb; 47(2):389-95. PubMed ID: 6978782
[TBL] [Abstract][Full Text] [Related]
12. Infiltration density of HNK 1 positive cells in non-Hodgkin's lymphomas depends on histologic subtype: an in situ morphometric analysis.
Gattringer C; Radaszkiewicz T; Pfaller W; Huber H
Immunobiology; 1985 Apr; 169(3):280-91. PubMed ID: 3997199
[TBL] [Abstract][Full Text] [Related]
13. p27(Kip1) immunostaining for the differential diagnosis of small b-cell neoplasms in trephine bone marrow biopsies.
Kremer M; Dirnhofer S; Nickl A; Hoefler H; Quintanilla-Martínez L; Fend F
Mod Pathol; 2001 Oct; 14(10):1022-9. PubMed ID: 11598173
[TBL] [Abstract][Full Text] [Related]
14. Adhesion molecule expression in CD5-negative/CD10-negative chronic B-cell leukemias: comparison with non-Hodgkin's lymphomas and CD5-positive B-cell chronic lymphocytic leukemia.
Finn WG; Singleton TP; Schnitzer B; Ross CW; Stoolman LM
Hum Pathol; 2001 Jan; 32(1):66-73. PubMed ID: 11172297
[TBL] [Abstract][Full Text] [Related]
15. [Immunopathology of lymphatic systemic diseases].
Huber H; Gattringer C
Wien Klin Wochenschr; 1983 May; 95(10):319-26. PubMed ID: 6351444
[TBL] [Abstract][Full Text] [Related]
16. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
[TBL] [Abstract][Full Text] [Related]
17. Distribution of complement receptor subtypes in non-Hodgkin's lymphomas of B-cell origin.
Cossman J; Jaffe ES
Blood; 1981 Jul; 58(1):20-6. PubMed ID: 6972240
[TBL] [Abstract][Full Text] [Related]
18. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
19. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
20. Cellular distribution of a B-cell specific surface antigen (gp54) detected by a monoclonal antibody (anti-BL4).
Hashimi L; Wang CY; Al-Katib A; Koziner B
Cancer Res; 1986 Oct; 46(10):5431-7. PubMed ID: 3093065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
